علاج إصابة الكلى الحادة: الإدارة الداعمة القائمة على المرحلة

References

DOI: 10.1159/000339789

• In the absence of hemorrhagic shock, we suggest using isotonic crystalloids rather than colloids (albumin or starches) as initial management for expansion of intravascular volume in patients at risk for AKI or with AKI.
• Manage patients with AKI according to the stage and cause.
• Particular attention should be given to the assessment of the circulating volume and fluid administration, the prevention and/or treatment of hyperkalemia and metabolic acidosis, the knowledge of the changes in pharmacokinetics of many drugs with discontinuation of all potentially nephrotoxic drugs, and dose adaptation of drugs excreted by the kidneys to the patient's renal function.
• In critically ill patients, we suggest insulin therapy targeting plasma glucose 110-149 mg/dl (6.1-8.3 mmol/l).